NASDAQ: TRVI · Health Care / Biotechnology: Pharmaceutical Preparations

Trevi Therapeutics Inc.

How Trevi Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.0B

Price

$13.81

P/E

-38.5

EPS (TTM)

$-0.36

1-year return

30.5%

Dividend yield

0.0%

52-week range

$10.65–$14.32

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources